| Tumor Type . | N . | Sex (% of Women) . | Age (Min–Max) . |
|---|---|---|---|
| Corticotropinomas | 13 | 92% | 56 (18–79) |
| Somatotropinomas | 13 | 54% | 50 (29–64) |
| PRLomas | 3 | 33% | 25 (20–34) |
| NFPAs | 13 | 62% | 49 (24–75) |
| Tumor Type . | N . | Sex (% of Women) . | Age (Min–Max) . |
|---|---|---|---|
| Corticotropinomas | 13 | 92% | 56 (18–79) |
| Somatotropinomas | 13 | 54% | 50 (29–64) |
| PRLomas | 3 | 33% | 25 (20–34) |
| NFPAs | 13 | 62% | 49 (24–75) |
| Tumor Type . | N . | Sex (% of Women) . | Age (Min–Max) . |
|---|---|---|---|
| Corticotropinomas | 13 | 92% | 56 (18–79) |
| Somatotropinomas | 13 | 54% | 50 (29–64) |
| PRLomas | 3 | 33% | 25 (20–34) |
| NFPAs | 13 | 62% | 49 (24–75) |
| Tumor Type . | N . | Sex (% of Women) . | Age (Min–Max) . |
|---|---|---|---|
| Corticotropinomas | 13 | 92% | 56 (18–79) |
| Somatotropinomas | 13 | 54% | 50 (29–64) |
| PRLomas | 3 | 33% | 25 (20–34) |
| NFPAs | 13 | 62% | 49 (24–75) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
